Popular Boards

Review 1 Mention
Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
Mingchun Jiang2025
Jiaxin ChiYifan Qiao
Top 25% · 75th percentile
40 citations · Molecular Biology
Open Access

TLDR

Certain natural compounds from ginseng may help protect the brain from diseases like Parkinson's and Alzheimer's by reducing inflammation and cell damage.

Summary

1 Study Aim

The paper aims to summarize and investigate how ginsenosides (the main active compounds in ginseng), especially Rg1, Rb1, and rare types, can protect nerve cells in Parkinson's disease (PD) and Alzheimer's disease (AD). The authors also seek to uncover the biological pathways and targets involved in these protective effects using a method called network pharmacology (a way to map how drugs interact with many biological targets at once). Simply put: The study wants to find out how certain ginseng compounds might help treat brain diseases like Parkinson's and Alzheimer's.

2 Study Design

The authors conducted a review of existing scientific studies by searching databases like Elsevier, PubMed, and Google Scholar using keywords related to ginsenosides, Parkinson's disease, Alzheimer's disease, anti-inflammatory, antioxidant, and apoptosis (cell death). They also used network pharmacology to identify which biological targets and pathways are affected by ginsenosides Rg1 and Rb1 in PD and AD. This approach allowed them to map out how these compounds might work in the body. Simply put: The researchers looked at many past studies and used computer tools to see how ginseng compounds might help with brain diseases.

3 Findings

The review reveals that ginsenosides, especially Rg1, Rb1, and rare types, show strong neuroprotective effects in both Parkinson's and Alzheimer's diseases. These effects are mainly due to their ability to reduce inflammation, prevent cell death, and fight oxidative stress (damage caused by harmful molecules). The authors report that these benefits are linked to several key signaling pathways, including PI3K/Akt (a pathway that helps cells survive), BDNF/TrkB (important for brain cell growth), MAPKs, NF-κB, Nrf2, and Wnt/β-catenin. The paper suggests that network pharmacology is a useful way to find new treatment strategies for these diseases using ginsenosides. Simply put: The study found that ginseng compounds may protect the brain by blocking harmful processes and could lead to new ways to treat Parkinson's and Alzheimer's.

Abstract

Ginseng has been commonly used as a traditional Chinese medicine in Asian countries for thousands of years. Ginsenosides are the main pharmacologically active ingredients isolated from ginseng and have neuroprotective effects in the treatment of neurodegenerative disorders, such as Parkinson's disease (PD) and Alzheimer's disease (AD). To summarise and investigate the protective roles of ginsenosides and their underlying mechanisms in PD and AD, we used ‘‘Ginsenoside”, ‘‘Parkinson's disease”, ‘‘Alzheimer's disease”, ‘‘anti-inflammatory”, ‘‘antioxidant”, and ‘‘apoptosis” as keywords to search and extract relevant literature information from scientific databases such as Elsevier, PubMed, and Google Scholar databases. In particular, we used network pharmacology to identify the potential targets of ginsenosides Rg1 and Rb1 in PD and AD. By analysing the existing research advances and network pharmacology results, we found that the neuroprotective effects of ginsenosides, primarily mediated through anti-inflammation, anti-apoptosis and anti-oxidative stress, etc, may be associated with the PI3K/Akt, BDNF/TrkB, MAPKs, NF-κB, Nrf2 and Wnt/β-catenin signalling pathways. This review systematically summarises the different roles and mechanisms of ginsenosides Rg1, Rb1, and rare ginsenosides in PD and AD and provides new strategies for the treatment of neurodegenerative disorders. Network pharmacology provides a new research paradigm for the treatment of PD and AD using Rg1 and Rb1. • This paper summarised the different roles and mechanisms of ginsenosides Rg1, Rb1, and rare ginsenosides in PD and AD. • Network pharmacology was used to identify potential targets of ginsenosides Rg1 and Rb1 in PD and AD. • This paper elucidated signalling pathways associated with ginsenosides Rg1, Rb1 and rare ginsenosides against PD and AD.

Referenced In